Edit Symbol List
PURE: Stock Quote & Summary Data
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | $ 8.00 |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 148,302 |
| Previous Close | $ 1.99 |
| 52 Wk High / Low | $ 4.10 / $ 1.22 |
| Shares Outstanding | 34,126,000 |
| Market Value | $ 66,886,960 |
| P/E Ratio | NE |
| Forward P/E (1yr) | N/A |
| Earnings Per Share | $ -0.22 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | 0.89 |
| NASDAQ Official Open Price: | $ 1.95 |
| Date of NASDAQ Official Open Price: | Nov. 20, 2009 |
| NASDAQ Official Close Price: | $ 1.96 |
| Date of NASDAQ Official Close Price: | Nov. 20, 2009 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About PURE?
Ask your question about about PURE Bioscience (PURE) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
PURE Bioscience began as a provider of pharmaceutical water purification products for the pharmacy market. In 2000 we commenced investments in the development of novel bioscience technologies, and subsequent to the May 2005 sale of our Water Treatment Division we have been exclusively focused on the development and commercialization of our current and future bioscience products. We are expanding into markets with broad potential by developing new, proprietary bioscience products based upon our patented silver ion antimicrobial technologies and to a lesser extent our patent-pending boric acid based pesticide technologies. We are developing technology-based bioscience products, including our silver dihydrogen citrate-based antimicrobials, which we believe will provide best in class, non-toxic solutions to numerous global health challenges and represent innovative advances in diverse markets. ... More ...
Links to all PURE Bioscience (PURE) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for PURE |
||
|
Gutenberg Communications Receives Two MarCom Gold Awards from Association of Marketing and Communication Professionals - Business Wire 11/04/2009 9:00AM |
||
|
North Canton Company Fights Against H1N1 with New EPA Registered Hard Surface Disinfectant, Formulated for Use Around Children and Pets - PR Newswire 10/29/2009 11:00AM |
||
|
EPA-Registered Ionic Silver Disinfectant Effective Against 2009 H1N1 Flu Strain - Business Wire 10/27/2009 8:27AM |
||
|
PURE Bioscience Q4 09 Earnings Conference Call At 4:30 PM - RTT News 10/14/2009 2:17PM |
||
|
PURE Bioscience Reveals Alliance With Sales And Marketing Team Richmont Sciences, LLC - Quick Facts - RTT News 10/14/2009 8:56AM |
||
|
PURE Bioscience Expands Business Strategy with Sales and Marketing Alliance for Long-lasting, Broad Spectrum SDC Antimicrobial Products - Business Wire 10/14/2009 8:27AM |
||
|
PURE Bioscience Reports FY09 Loss - Quick Facts - RTT News 10/13/2009 4:43PM |



Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
1.51%
